{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:01:04Z","timestamp":1761580864094,"version":"3.38.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T00:00:00Z","timestamp":1298678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00467-011-1812-2","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T19:48:05Z","timestamp":1298663285000},"page":"705-717","source":"Crossref","is-referenced-by-count":32,"title":["Monitoring and managing viral infections in pediatric renal transplant recipients"],"prefix":"10.1007","volume":"27","author":[{"given":"Patrizia","family":"Comoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Ginevri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,26]]},"reference":[{"key":"1812_CR1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","volume":"338","author":"JA Fishman","year":"1998","unstructured":"Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338:1741\u20131751","journal-title":"N Engl J Med"},{"key":"1812_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-6143.2004.00350.x","volume":"4","author":"VR Dharnidharka","year":"2004","unstructured":"Dharnidharka VR, Stablein DM, Harmon WE (2004) Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant 4:384\u2013389","journal-title":"Am J Transplant"},{"key":"1812_CR3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/431488","volume":"41","author":"HH Hirsch","year":"2005","unstructured":"Hirsch HH (2005) BK virus: opportunity makes a pathogen. Clin Infect Dis 41:354\u2013360","journal-title":"Clin Infect Dis"},{"key":"1812_CR4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/TP.0b013e31818b6548","volume":"86","author":"SA Fischer","year":"2008","unstructured":"Fischer SA (2008) Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation 86:1327\u20131339","journal-title":"Transplantation"},{"key":"1812_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","volume":"6","author":"A Humar","year":"2006","unstructured":"Humar A, Michaels M (2006) American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6:262","journal-title":"Am J Transplant"},{"key":"1812_CR6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","volume":"89","author":"CN Kotton","year":"2010","unstructured":"Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A, Transplantation Society International CMV Consensus Group (2010) International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 89:779\u2013795","journal-title":"Transplantation"},{"key":"1812_CR7","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1128\/JCM.00913-08","volume":"46","author":"F Baldanti","year":"2008","unstructured":"Baldanti F, Gatti M, Furione M, Paolucci S, Tinelli C, Comoli P, Merli P, Locatelli F (2008) Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell depleted HLA-haploidentical stem cell transplantation. J Clin Microbiol 46:3672\u20133677","journal-title":"J Clin Microbiol"},{"key":"1812_CR8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM200005043421802","volume":"342","author":"V Nickeleit","year":"2000","unstructured":"Nickeleit V, Klimkait T, Binet IF Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH (2000) Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342:1309\u20131315","journal-title":"N Engl J Med"},{"key":"1812_CR9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-200205270-00014","volume":"73","author":"F Smets","year":"2002","unstructured":"Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM (2002) Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73:1603\u20131610","journal-title":"Transplantation"},{"key":"1812_CR10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MOT.0b013e3283186b93","volume":"13","author":"F Ginevri","year":"2008","unstructured":"Ginevri F, Hirsch HH, Comoli P (2008) Cellular immune responses to BK virus. Curr Opin Organ Transplant 13:569\u2013574","journal-title":"Curr Opin Organ Transplant"},{"key":"1812_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9\u201312","journal-title":"Lancet"},{"key":"1812_CR12","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","volume":"107","author":"S Choquet","year":"2006","unstructured":"Choquet S, Leblond V, Herbrecht R, Soci\u00e9 G, Stoppa AM, Vandenberghe P, Fischer A, Morschhauser F, Salles G, Feremans W, Vilmer E, Peraldi MN, Lang P, Lebranchu Y, Oksenhendler E, Garnier JL, Lamy T, Jaccard A, Ferrant A, Offner F, Hermine O, Moreau A, Fafi-Kremer S, Morand P, Chatenoud L, Berriot-Varoqueaux N, Bergougnoux L, Milpied N (2006) Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 107:3053\u20133057","journal-title":"Blood"},{"key":"1812_CR13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","volume":"4","author":"C Paya","year":"2004","unstructured":"Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Pescovitz MD, Valganciclovir Solid Organ Transplant Study Group (2004) Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4:611\u2013620","journal-title":"Am J Transplant"},{"key":"1812_CR14","first-page":"759","volume":"131","author":"RF Betts","year":"1977","unstructured":"Betts RF, Freeman RB, Douglas RG Jr, Talley TE (1977) Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131:759\u2013763","journal-title":"Am J Dis Child"},{"key":"1812_CR15","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","volume":"261","author":"RH Rubin","year":"1989","unstructured":"Rubin RH (1989) The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 261:3607\u20133609","journal-title":"JAMA"},{"key":"1812_CR16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QCO.0b013e328285a358","volume":"20","author":"RH Rubin","year":"2007","unstructured":"Rubin RH (2007) The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the \u2018silo hypothesis\u2019. Curr Opin Infect Dis 20:399\u2013407","journal-title":"Curr Opin Infect Dis"},{"key":"1812_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1399-3046.2007.00781.x","volume":"12","author":"B Kranz","year":"2008","unstructured":"Kranz B, Vester U, Wingen AM, Nadalin S, Paul A, Broelsch CE, Hoyer PF (2008) Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant 12:474\u2013478","journal-title":"Pediatr Transplant"},{"key":"1812_CR18","unstructured":"Paya CV, Razonable RR (2003) Cytomegalovirus infection after organ transplantation. In:Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections, 2nd Edn. Lippincott, Williams, and Wilkins, pp 298\u2013 325"},{"key":"1812_CR19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","volume":"5","author":"JK Preiksaitis","year":"2005","unstructured":"Preiksaitis JK, Brennan DC, Fishman J, Allen U (2005) Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 5:218\u2013227","journal-title":"Am J Transplant"},{"key":"1812_CR20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/JCM.25.5.755-757.1987","volume":"25","author":"CV Paya","year":"1987","unstructured":"Paya CV, Wold AD, Smith TF (1987) Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures. J Clin Microbiol 25:755\u2013757","journal-title":"J Clin Microbiol"},{"key":"1812_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/infdis\/164.2.265","volume":"164","author":"AP Berg van den","year":"1991","unstructured":"van den Berg AP, Klompmaker IJ, Haagsma EB, Haagsma EB, Scholten-Sampson A, Bijleveld CM, Schirm J, van der Giessen M, Slooff MJ, The TH (1991) Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis 164:265\u2013270","journal-title":"J Infect Dis"},{"key":"1812_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.1994.tb04978.x","volume":"88","author":"F Locatelli","year":"1994","unstructured":"Locatelli F, Percivalle E, Comoli P, Maccario R, Zecca M, Giorgiani G, De Stefano P, Gerna G (1994) Human cytomegalovirus (HCMV) infection in pediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenemia on patients\u2019 outcome. Br J Haematol 88:64\u201371","journal-title":"Br J Haematol"},{"key":"1812_CR23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","volume":"143","author":"AC Kalil","year":"2005","unstructured":"Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG (2005) Metaanalysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 143:870\u2013880","journal-title":"Ann Intern Med"},{"key":"1812_CR24","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1681\/ASN.2009111188","volume":"21","author":"JM Smith","year":"2010","unstructured":"Smith JM, Corey L, Bittner R, Finn LS, Healey PJ, Davis CL, McDonald RA (2010) Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J Am Soc Nephrol 21:1579\u20131586","journal-title":"J Am Soc Nephrol"},{"key":"1812_CR25","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","volume":"6","author":"JA Khoury","year":"2006","unstructured":"Khoury JA, Storch GA, Bohl DL, Schuessler RM, Torrence SM, Lockwood M, Gaudreault-Keener M, Koch MJ, Miller BW, Hardinger KL, Schnitzler MA, Brennan DC (2006) Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 6:2134\u20132143","journal-title":"Am J Transplant"},{"key":"1812_CR26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg E, Punch J, Limaye A, Abramowicz D, Jardine A, Voulgari A, Ives J, Hauser I, Peeters P (2010) The efficacy and safety of 200\u00a0days valganciclovir cytomegalovirus prophylaxis in high risk kidney transplant recipients. Am J Transplant 10:1228\u20131237","journal-title":"Am J Transplant"},{"key":"1812_CR27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1399-0012.2009.01077.x","volume":"23","author":"R San Juan","year":"2009","unstructured":"San Juan R, Yebra M, Lumbreras C, L\u00f3pez-Medrano F, Lizasoain M, Meneu JC, Delgado J, Andr\u00e9s A, Aguado JM (2009) A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+\/R-) solid organ transplant recipients. Clin Transplant 23:666\u2013671","journal-title":"Clin Transplant"},{"key":"1812_CR28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jcv.2008.03.031","volume":"42","author":"SK Sanghavi","year":"2008","unstructured":"Sanghavi SK, Abu-Elmagd K, Keightley MC, St George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR (2008) Relationship of cytomegalovirus load assessed by real-time PCR to pp 65 antigenemia in organ transplant recipients. J Clin Virol 42:335\u2013342","journal-title":"J Clin Virol"},{"key":"1812_CR29","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","volume":"355","author":"VC Emery","year":"2000","unstructured":"Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000) Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032\u20132036","journal-title":"Lancet"},{"key":"1812_CR30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1399-0012.1997.tb01053.x","volume":"11","author":"MD Pescovitz","year":"1997","unstructured":"Pescovitz MD, Brook B, Jindal RM, Leapman SB, Milgram MG, Filo RS (1997) Oral ganciclovir in pediatric transplant recipients: A pharmacokinetic study. Clin Transplant 11:613\u2013617","journal-title":"Clin Transplant"},{"key":"1812_CR31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-6143.2008.02528.x","volume":"9","author":"W Vaudry","year":"2009","unstructured":"Vaudry W, Ettenger R, Jara P, Varela-Fascinetto G, Bouw MR, Ives J, Walker R, Valcyte WV16726 Study Group (2009) Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant 9:636\u2013643","journal-title":"Am J Transplant"},{"key":"1812_CR32","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/379376","volume":"188","author":"G Gerna","year":"2003","unstructured":"Gerna G, Sarasini A, Lilleri D, Percivalle E, Torsellini M, Baldanti F, Revello MG (2003) In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients. J Infect Dis 188:1639\u20131647","journal-title":"J Infect Dis"},{"key":"1812_CR33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","volume":"356","author":"AP Limaye","year":"2000","unstructured":"Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M (2000) Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 356:645\u2013649","journal-title":"Lancet"},{"key":"1812_CR34","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","volume":"79","author":"HH Hirsch","year":"2005","unstructured":"Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, Mihatsch MJ, Nickeleit V, Ramos E, Randhawa P, Shapiro R, Steiger J, Suthanthiran M, Trofe J (2005) Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277\u20131286","journal-title":"Transplantation"},{"key":"1812_CR35","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","volume":"68","author":"B Vasudev","year":"2005","unstructured":"Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP (2005) BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 68:1834\u20131839","journal-title":"Kidney Int"},{"key":"1812_CR36","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","volume":"13","author":"E Ramos","year":"2002","unstructured":"Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, Drachenberg RC, Wiland A, Wali R, Cangro CB, Schweitzer E, Bartlett ST, Weir MR (2002) Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13:2145\u20132151","journal-title":"J Am Soc Nephrol"},{"key":"1812_CR37","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1432-2277.2009.00842.x","volume":"22","author":"JD Schold","year":"2009","unstructured":"Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU (2009) Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 22:626\u2013634","journal-title":"Transpl Int"},{"key":"1812_CR38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","volume":"3","author":"HH Hirsch","year":"2003","unstructured":"Hirsch HH, Steiger J (2003) Polyomavirus BK. Lancet Infect Dis 3:611\u2013623","journal-title":"Lancet Infect Dis"},{"key":"1812_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/498530","volume":"193","author":"GA Funk","year":"2006","unstructured":"Funk GA, Steiger J, Hirsch HH (2006) Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 193:80\u201387","journal-title":"J Infect Dis"},{"key":"1812_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00007890-199901150-00018","volume":"67","author":"PS Randhawa","year":"1999","unstructured":"Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, Picken MM, Demetris AJ (1999) Human Polyoma virus-associated interstial nephritis in the allograft kidney. Transplantation 67:103\u2013109","journal-title":"Transplantation"},{"key":"1812_CR41","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1046\/j.1600-6143.2004.00603.x","volume":"4","author":"CB Drachenberg","year":"2004","unstructured":"Drachenberg CB, Papadimitriou JC, Hirsch HH, Wali R, Crowder C, Nogueira J, Cangro CB, Mendley S, Mian A, Ramos E (2004) Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplantation 4:2082\u20132092","journal-title":"Am J Transplantation"},{"key":"1812_CR42","volume-title":"Evidence-Based Nephrology","author":"F Ginevri","year":"2008","unstructured":"Ginevri F, Hirsch HH (2008) Polyomavirus-associated nephropathy. In: Molony DA, Craig JC (eds) Evidence-Based Nephrology. John Wiley & Sons, London"},{"key":"1812_CR43","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00467-007-0462-x","volume":"22","author":"PD Acott","year":"2007","unstructured":"Acott PD, Hirsch HH (2007) BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 22:1243\u20131250","journal-title":"Pediatr Nephrol"},{"key":"1812_CR44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","volume":"87","author":"VR Dharnidharka","year":"2009","unstructured":"Dharnidharka VR, Cherikh WS, Abbott KC (2009) An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation 87:1019\u20131026","journal-title":"Transplantation"},{"key":"1812_CR45","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.TP.0000061767.32870.72","volume":"75","author":"F Ginevri","year":"2003","unstructured":"Ginevri F, De Santis R, Comoli P, Pastorino N, Rossi C, Botti G, Fontana I, Nocera A, Cardillo M, Ciardi MR, Locatelli F, Maccario R, Perfumo F, Azzi A (2003) Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 75:1266\u20131270","journal-title":"Transplantation"},{"key":"1812_CR46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3046.2004.00154.x","volume":"8","author":"L Haysom","year":"2004","unstructured":"Haysom L, Rosenberg AR, Kainer G, Waliuzzaman ZM, Roberts J, Rawlinson WD, Mackie FE (2004) BK viral infection in an Australian pediatric renal transplant population. Pediatr Transplant 8:480\u2013484","journal-title":"Pediatr Transplant"},{"key":"1812_CR47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-3046.2004.00211.x","volume":"8","author":"J Herman","year":"2004","unstructured":"Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R (2004) Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transplant 8:485\u2013492","journal-title":"Pediatr Transplant"},{"key":"1812_CR48","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1399-3046.2006.00539.x","volume":"10","author":"RT Alexander","year":"2006","unstructured":"Alexander RT, Langlois V, Tellier R, Robinson L, Hebert D (2006) The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: a single-center retrospective analysis. Pediatr Transplant 10:586\u2013592","journal-title":"Pediatr Transplant"},{"key":"1812_CR49","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2215\/CJN.04051206","volume":"2","author":"JM Smith","year":"2007","unstructured":"Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA (2007) BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2:1037\u20131042","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"1812_CR50","first-page":"S44","volume":"9","author":"KDIGO Guidelines","year":"2009","unstructured":"KDIGO Guidelines (2009) Am J Transplant 9(Suppl 3):S44\u2013S58","journal-title":"Am J Transplant"},{"key":"1812_CR51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","volume":"347","author":"HH Hirsch","year":"2002","unstructured":"Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J (2002) Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347:488\u2013496","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"1812_CR52","first-page":"S136","volume":"9","author":"P Hirsch HH Randhawa","year":"2009","unstructured":"Hirsch HH Randhawa P, AST Infectious Diseases Community of Practice (2009) BK virus in solid organ transplant recipients. Am J Transplant 9(Suppl 4):S136\u2013S146","journal-title":"Am J Transplant"},{"key":"1812_CR53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","volume":"5","author":"DC Brennan","year":"2005","unstructured":"Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA (2005) Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5:582\u2013594","journal-title":"Am J Transplant"},{"key":"1812_CR54","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/j.1600-6143.2007.01984.x","volume":"7","author":"F Ginevri","year":"2007","unstructured":"Ginevri F, Azzi A, Hirsch HH, Basso S, Fontana I, Cioni M, Bodaghi S, Salotti V, Rinieri A, Botti G, Perfumo F, Locatelli F, Comoli P (2007) Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 7:2727\u20132735","journal-title":"Am J Transplant"},{"key":"1812_CR55","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/TP.0b013e318166cba8","volume":"85","author":"ER Saad","year":"2008","unstructured":"Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S (2008) Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 85:850\u2013854","journal-title":"Transplantation"},{"key":"1812_CR56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00007890-200301150-00020","volume":"75","author":"A Vats","year":"2003","unstructured":"Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, Moritz ML, Beattie TJ, Gonwa T, Green MD, Ellis D (2003) Quantitative viral load monitoring and cidofovir therapy for the management of BK virus associated nephropathy in children and adults. Transplantation 75:105\u2013112","journal-title":"Transplantation"},{"key":"1812_CR57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1600-6143.2001.10202.x","volume":"1","author":"M Green","year":"2001","unstructured":"Green M (2001) Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 1:103\u2013108","journal-title":"Am J Transplant"},{"key":"1812_CR58","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2003","unstructured":"Opelz G, Dohler B (2003) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4:222\u2013230","journal-title":"Am J Transplant"},{"key":"1812_CR59","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3324\/haematol.2010.023689","volume":"95","author":"A Merlo","year":"2010","unstructured":"Merlo A, Turrini R, Dolcetti R, Martorelli D, Muraro E, Comoli P, Rosato A (2010) The interplay between EBV and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haematologica 95:1769\u20131777","journal-title":"Haematologica"},{"key":"1812_CR60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/snep.2001.24947","volume":"21","author":"VR Dharnidharka","year":"2001","unstructured":"Dharnidharka VR, Harmon WE (2001) Management of pediatric postrenal transplantation infections. Semin Nephrol 21:521\u2013531","journal-title":"Semin Nephrol"},{"key":"1812_CR61","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","volume":"80","author":"S Caillard","year":"2005","unstructured":"Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233\u20131243","journal-title":"Transplantation"},{"key":"1812_CR62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","volume":"71","author":"VR Dharnidharka","year":"2001","unstructured":"Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE (2001) Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71:1065\u20131068","journal-title":"Transplantation"},{"key":"1812_CR63","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","volume":"7","author":"AD Kirk","year":"2007","unstructured":"Kirk AD, Cherikh WS, Ring M, Burke G, Kaufman D, Knechtle SJ, Potdar S, Shapiro R, Dharnidharka VR, Kauffman HM (2007) Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant 7:2619\u20132625","journal-title":"Am J Transplant"},{"key":"1812_CR64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","volume":"8","author":"RA McDonald","year":"2008","unstructured":"McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, Wyatt R, Arar M, Liereman D, Bridges N, Harmon W, CCTPT Study Group (2008) Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 8:984\u2013989","journal-title":"Am J Transplant"},{"key":"1812_CR65","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, France"},{"key":"1812_CR66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343:481\u2013492","journal-title":"N Engl J Med"},{"key":"1812_CR67","first-page":"173","volume":"133","author":"M Nalesnik","year":"1988","unstructured":"Nalesnik M, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 133:173\u2013192","journal-title":"Am J Pathol"},{"key":"1812_CR68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.38.2.613-619.2000","volume":"38","author":"F Baldanti","year":"2000","unstructured":"Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, Maccario R, Fiocchi R, Gerna G (2000) High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 38:613\u2013619","journal-title":"J Clin Microbiol"},{"key":"1812_CR69","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood.V96.13.4055","volume":"96","author":"J Yang","year":"2000","unstructured":"Yang J, Tao Q, Flinn IW, Murray PG, Post LE, Ma H, Piantadosi S, Caligiuri MA, Ambinder RF (2000) Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 96:4055\u20134063","journal-title":"Blood"},{"key":"1812_CR70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3062.2001.003002079.x","volume":"3","author":"DT Rowe","year":"2001","unstructured":"Rowe DT, Webber S, Schauer EM, Reyes J, Green M (2001) Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis 3:79\u201387","journal-title":"Transpl Infect Dis"},{"key":"1812_CR71","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1600-6143.2005.00854.x","volume":"5","author":"P Comoli","year":"2005","unstructured":"Comoli P, Maccario R, Locatelli F, Valente U, Basso S, Garaventa A, Tom\u00e0 P, Botti G, Melioli G, Baldanti F, Nocera A, Perfumo F, Ginevri F (2005) Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells. Am J Transplant 5:1415\u20131422","journal-title":"Am J Transplant"},{"key":"1812_CR72","first-page":"351","volume-title":"Epstein-Barr virus","author":"P Comoli","year":"2006","unstructured":"Comoli P, Rooney CM (2006) Treatment of Epstein-Barr virus infections. In: Jenson HB, Tselis A (eds) Epstein-Barr virus. Taylor & Francis, New York, pp 351\u2013372"},{"key":"1812_CR73","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood.V86.9.3333.bloodjournal8693333","volume":"86","author":"LJ Swinnen","year":"1995","unstructured":"Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI (1995) Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 86:3333\u20133340","journal-title":"Blood"},{"key":"1812_CR74","first-page":"67","volume":"87","author":"G Muti","year":"2002","unstructured":"Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E (2002) Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica 87:67\u201377","journal-title":"Haematologica"},{"key":"1812_CR75","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","volume":"1","author":"TE Starzl","year":"1984","unstructured":"Starzl TE, Porter KA, Iwatsuki JT, Rosenthal BW, Shaw RW Jr, Atchison MA, Nalesnik M Ho, Griffith BP, Hakala TR, Hardesty RL, Jaffe R, Bahnson HT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583","journal-title":"Lancet"},{"key":"1812_CR76","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1182\/blood-2002-01-0210","volume":"100","author":"P Porcu","year":"2002","unstructured":"Porcu P, Eisenbeis CF, Pelletier RP, Davies EA, Baiocchi RA, Roychowdhury S, Vourganti S, Nuovo GJ, Marsh WL, Ferketich AK, Henry ML, Ferguson RM, Caligiuri MA (2002) Successful treatment of posttransplant lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8+ T-cell restoration. Blood 100:2341\u20132348","journal-title":"Blood"},{"key":"1812_CR77","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","volume":"109","author":"SP Perrine","year":"2007","unstructured":"Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV (2007) A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood 109:2571\u20132578","journal-title":"Blood"},{"key":"1812_CR78","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1200\/JCO.2005.08.074","volume":"23","author":"TG Gross","year":"2005","unstructured":"Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC (2005) Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol 23:6481\u20136488","journal-title":"J Clin Oncol"},{"key":"1812_CR79","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V83.9.2715.2715","volume":"83","author":"A Savoie","year":"1994","unstructured":"Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715\u20132722","journal-title":"Blood"},{"key":"1812_CR80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-6143.2007.02080.x","volume":"8","author":"MA Bingler","year":"2008","unstructured":"Bingler MA, Feingold B, Miller SA, Quivers E, Michaels MG, Green M, Wadowsky RM, Rowe DT, Webber SA (2008) Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease\/lymphoma in children. Am J Transplant 8:442\u20135","journal-title":"Am J Transplant"},{"key":"1812_CR81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1399-3046.2009.01283.x","volume":"14","author":"AH Lau","year":"2010","unstructured":"Lau AH, Soltys K, Sindhi RK, Bond G, Mazareigos G, Green M (2010) Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients. Pediatr Transplant 14:549\u2013553","journal-title":"Pediatr Transplant"},{"key":"1812_CR82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1399-3046.2008.00926.x","volume":"13","author":"M Green","year":"2009","unstructured":"Green M, Soltys K, Rowe DT, Webber SA, Mazareigos G (2009) Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Pediatr Transplant 13:319\u2013323","journal-title":"Pediatr Transplant"},{"issue":"s2","key":"1812_CR83","first-page":"477","volume":"8","author":"F Ginevri","year":"2008","unstructured":"Ginevri F, Di Marco E, Parodi A, Gurrado A, Cirillo C, Botti G, Fontana I, Valente U, Locatelli F, Comoli P (2008) EBV viral load monitoring and reduction of immunosuppression do not successfully prevent PTLD after pediatric kidney transplantation. Am J Transplant 8(s2):477","journal-title":"Am J Transplant"},{"key":"1812_CR84","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","volume":"5","author":"TC Lee","year":"2005","unstructured":"Lee TC, Savoldo B, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Barshes NR, Scott JD, Bristow LJ, O'Mahony CA, Goss JA (2005) Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 5:2222\u20132228","journal-title":"Am J Transplant"},{"key":"1812_CR85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2007-976494","volume":"28","author":"Y Kim","year":"2007","unstructured":"Kim Y, Boeckh M, Eglund JA (2007) Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 28:222\u2013242","journal-title":"Semin Respir Crit Care Med"},{"key":"1812_CR86","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/JCM.00216-06","volume":"44","author":"J Kuypers","year":"2006","unstructured":"Kuypers J, Wright N, Ferrenberg J, Huang ML, Cent A, Corey L, Morrow R (2006) Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 44:2382\u20132388","journal-title":"J Clin Microbiol"},{"key":"1812_CR87","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1399-3046.2006.00583.x","volume":"10","author":"SS Blanchard","year":"2006","unstructured":"Blanchard SS, Gerrek M, Siegel C, Czinn SJ (2006) Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 10:826\u2013829","journal-title":"Pediatr Transplant"},{"key":"1812_CR88","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/clinids\/20.2.394","volume":"20","author":"AM Apalsch","year":"1995","unstructured":"Apalsch AM, Green M, Ledesma-Medina J, Nour B, Wald ER (1995) Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 20:394\u2013399","journal-title":"Clin Infect Dis"},{"key":"1812_CR89","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00007890-200104150-00029","volume":"71","author":"H Ardehall","year":"2000","unstructured":"Ardehall H, Volmar K, Roberts C, Huang ML, Cent A, Corey L, Morrow R (2000) Fatal disseminated adenoviral infection in a renal transplant patient. Transplantation 71:998","journal-title":"Transplantation"},{"key":"1812_CR90","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM200105173442002","volume":"344","author":"GS Shirali","year":"2001","unstructured":"Shirali GS, Ni J, Chinnock RE, Johnston JK, Rosenthal GL, Bowles NE, Towbin JA (2001) Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 344:1498\u20131503","journal-title":"N Engl J Med"},{"key":"1812_CR91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.healun.2008.10.008","volume":"28","author":"A Pelaez","year":"2009","unstructured":"Pelaez A, Lyon GM, Force SD, Ramirez AM, Neujahr DC, Foster M, Naik PM, Gal AA, Mitchell PO, Lawrence EC (2009) Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 28:67\u201371","journal-title":"J Heart Lung Transplant"},{"key":"1812_CR92","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e3181343b7e","volume":"26","author":"S Ch\u00e1vez-Bueno","year":"2007","unstructured":"Ch\u00e1vez-Bueno S, Mej\u00edas A, Merryman RA, Ahmad N, Jafri HS, Ramilo O (2007) Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 26:1089\u20131093","journal-title":"Pediatr Infect Dis J"},{"key":"1812_CR93","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1053-2498(02)00569-7","volume":"22","author":"LH McCurdy","year":"2003","unstructured":"McCurdy LH, Milstone A, Dummer S (2003) Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 22:745\u2013753","journal-title":"J Heart Lung Transplant"},{"key":"1812_CR94","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","volume":"20","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills RG, Ward P (2001) Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20:127\u2013133","journal-title":"Pediatr Infect Dis J"},{"key":"1812_CR95","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200210150-00027","volume":"74","author":"BA Carter","year":"2002","unstructured":"Carter BA, Karpen SJ, Quiros-Tejeira RE, Chang IF, Clark BS, Demmler GJ, Heslop HE, Scott JD, Seu P, Goss JA (2002) Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation 74:1050\u20131052","journal-title":"Transplantation"},{"key":"1812_CR96","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPH.0b013e3180437ded","volume":"29","author":"NJ Thomas","year":"2007","unstructured":"Thomas NJ, Hollenbeck CS, Ceneviva GD, Geskey JM, Young MJ (2007) Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: A decision analysis model. J Pediatr Hematol\/Oncol 29:227\u2013232","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"1812_CR97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-6143.2007.02066.x","volume":"8","author":"J Scharp\u00e9","year":"2008","unstructured":"Scharp\u00e9 J, Evenepoel P, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Peetermans WE (2008) Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8:332\u2013337","journal-title":"Am J Transplant"},{"key":"1812_CR98","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1365-2141.2003.04048.x","volume":"120","author":"DA Clark","year":"2003","unstructured":"Clark DA, Griffiths PD (2003) Human herpesvirus 6: relevance of infection in the immunocompromised host. Br J Haematol 120:384\u2013395","journal-title":"Br J Haematol"},{"key":"1812_CR99","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3748\/wjg.15.2561","volume":"15","author":"RC Abdel Massih","year":"2009","unstructured":"Abdel Massih RC, Razonable RR (2009) Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol 15:2561\u20132569","journal-title":"World J Gastroenterol"},{"key":"1812_CR100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/317929","volume":"183","author":"JC Mendez","year":"2001","unstructured":"Mendez JC, Dockrell DH, Espy MJ, Smith TF, Wilson JA, Harmsen WS, Ilstrup D, Paya CV (2001) Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 183:179\u2013184","journal-title":"J Infect Dis"},{"key":"1812_CR101","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/466529","volume":"192","author":"RR Razonable","year":"2005","unstructured":"Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV (2005) Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 192:1331\u20131339","journal-title":"J Infect Dis"},{"key":"1812_CR102","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1399-3046.2003.00099.x","volume":"7","author":"M Gupta","year":"2003","unstructured":"Gupta M, Diaz-Mitoma F, Feber J, Shaw L, Forget C, Filler G (2003) Tissue HHV6 and 7 determination in pediatric solid organ recipients: a pilot study. Pediatr Transplant 7:458\u2013463","journal-title":"Pediatr Transplant"},{"key":"1812_CR103","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7326\/0003-4819-124-12-199606150-00007","volume":"124","author":"N Singh","year":"1996","unstructured":"Singh N, Carrigan DR (1996) Human Herpesvirus-6 in transplantation: An emerging pathogen. Ann Intern Med 124:1065\u20131071","journal-title":"Ann Intern Med"},{"key":"1812_CR104","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1600-6143.2004.00459.x","volume":"4","author":"PJ Nash","year":"2004","unstructured":"Nash PJ, Avery RK, Tang WH, Starling RC, Taege AJ, Yamani MH (2004) Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant 4:1200\u20131203","journal-title":"Am J Transplant"},{"key":"1812_CR105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000066172","volume":"48","author":"M Montejo","year":"2002","unstructured":"Montejo M, Ramon Fernandez J, Testillano M, Valdivieso A, Aguirrebengoa K, Varas C, Olaizola A, De Urbina JO (2002) Encephalitis caused by human herpesvirus-6 in a liver transplant recipient. Eur Neurol 48:234\u2013235","journal-title":"Eur Neurol"},{"key":"1812_CR106","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/095632029700800102","volume":"8","author":"K Takahashi","year":"1997","unstructured":"Takahashi K, Suzuki M, Iwata Y, Shigeta S, Yamanishi K, De Clercq E (1997) Selective activity of various nucleoside and nucleotide analogues against human herpesvirus 6 and 7. Antivir Chem Chemother 8:24\u201331","journal-title":"Antivir Chem Chemother"},{"key":"1812_CR107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V95.1.241","volume":"95","author":"J Yang","year":"2000","unstructured":"Yang J, Lemas VM, Flinn IW, Krone C, Ambinder RF (2000) Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens. Blood 95:241\u2013248","journal-title":"Blood"},{"key":"1812_CR108","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/01.TP.0000137932.44791.D3","volume":"78","author":"P Comoli","year":"2004","unstructured":"Comoli P, Azzi A, Maccario R, Basso S, Botti G, Basile G, Fontana I, Labirio M, Cometa A, Poli F, Perfumo F, Locatelli F, Ginevri F (2004) Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78:1229\u20131232","journal-title":"Transplantation"},{"key":"1812_CR109","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1600-6143.2008.02191.x","volume":"8","author":"FM Mattes","year":"2008","unstructured":"Mattes FM, Vargas A, Kopycinski J, Hainsworth EG, Sweny P, Nebbia G, Bazeos A, Lowdell M, Klenerman P, Phillips RE, Griffiths PD, Emery VC (2008) Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High-Level Replication After Renal Transplantation. Am J Transplant 8:990\u2013999","journal-title":"Am J Transplant"},{"key":"1812_CR110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","volume":"9","author":"D Kumar","year":"2009","unstructured":"Kumar D, Chernenko S, Moussa G, Cobos I, Manuel O, Preiksaitis J, Venkataraman S, Humar A (2009) Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant 9:1214\u20131222","journal-title":"Am J Transplant"},{"key":"1812_CR111","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1600-6143.2004.00693.x","volume":"5","author":"B Savoldo","year":"2005","unstructured":"Savoldo B, Rooney CM, Quiros-Tejeira RE, Caldwell Y, Wagner HJ, Lee T, Finegold MJ, Dotti G, Heslop HE, Goss JA (2005) Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. Am J Transplant 5:566\u2013572","journal-title":"Am J Transplant"},{"key":"1812_CR112","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2008.02279.x","volume":"8","author":"U Sester","year":"2008","unstructured":"Sester U, Presser D, Dirks J, Gartner BC, Kohler H, Sester M (2008) PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant 8:1486\u20131497","journal-title":"Am J Transplant"},{"key":"1812_CR113","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1600-6143.2007.01754.x","volume":"7","author":"S Binggeli","year":"2007","unstructured":"Binggeli S, Egli A, Schaub S, Binet I, Mayr M, Steiger J, Hirsch HH (2007) Polyomavirus BK-specific cellular immune response to VP1 and Large T-antigen in kidney transplant recipients. Am J Transplant 7:1131\u20131139","journal-title":"Am J Transplant"},{"key":"1812_CR114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/TP.0b013e31815fef56","volume":"85","author":"SE Prosser","year":"2008","unstructured":"Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S (2008) Recovery of BK virus Large-T-antigen-specific cellular immune response correlates with resolution of BK virus nephropathy. Transplantation 85:185\u2013192","journal-title":"Transplantation"},{"key":"1812_CR115","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","volume":"201","author":"T Bunde","year":"2005","unstructured":"Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F (2005) Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201:1031\u20131036","journal-title":"J Exp Med"},{"key":"1812_CR116","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","volume":"115","author":"HE Heslop","year":"2010","unstructured":"Heslop HE, Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA, Bollard CM, Liu H, Wu MF, Rochester RJ, Amrolia PJ, Hurwitz JL, Brenner MK, Rooney CM (2010) Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115:925\u2013935","journal-title":"Blood"},{"key":"1812_CR117","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038\u20131044","journal-title":"N Engl J Med"},{"key":"1812_CR118","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","volume":"116","author":"T Feuchtinger","year":"2010","unstructured":"Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM, Mohty M, Or R, Maschan M, Schumm M, Hamprecht K, Handgretinger R, Lang P, Einsele H (2010) Adoptive transfer of pp 65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 116:4360\u20134367","journal-title":"Blood"},{"key":"1812_CR119","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00075200-200212000-00003","volume":"7","author":"P Comoli","year":"2002","unstructured":"Comoli P, Locatelli F, Ginevri F, Maccario R (2002) Cellular immunotherapy for viral infections in solid organ transplant recipients. Curr Opin Organ Transplant 7:314\u2013319","journal-title":"Curr Opin Organ Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1812-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-011-1812-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1812-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:05:58Z","timestamp":1740963958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-011-1812-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,26]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1007\/s00467-011-1812-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2011,2,26]]}}}